# Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

> **NCT04460547** · — · UNKNOWN · sponsor: **Qassim University** · enrollment: 200 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Convalescent Plasma Transfusion
- **DRUG:** Hydroxychloroquine
- **DRUG:** DAS181
- **DRUG:** Ivermectin
- **DRUG:** Interferon Beta-1A

## Key facts

- **NCT ID:** NCT04460547
- **Lead sponsor:** Qassim University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-25
- **Primary completion:** 2020-08-15
- **Final completion:** 2020-09-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04460547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04460547, "Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04460547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*